Welcome to our dedicated page for Aurora Spine news (Ticker: ASAPF), a resource for investors and traders seeking the latest updates and insights on Aurora Spine stock.
Aurora Spine Corporation (ASAPF) delivers innovative spinal implant technologies focused on minimally invasive surgical solutions and regenerative approaches. This news hub provides investors and healthcare professionals with essential updates on the company’s financial developments, product milestones, and clinical advancements.
Access timely announcements including quarterly earnings reports, regulatory approvals for new devices, and strategic partnerships within the medical device sector. Our curated collection ensures transparent tracking of Aurora Spine’s progress in improving spinal care through screwless implant systems and biointegrated solutions.
Discover press releases covering FDA clearances, research collaborations, and executive leadership changes that shape the company’s trajectory. All content is verified for accuracy and relevance to support informed decision-making about ASAPF’s market position and technological contributions.
Bookmark this page for streamlined access to Aurora Spine’s latest developments in spinal healthcare innovation. Check regularly for updates on patent filings, clinical trial results, and industry recognition of their patient-focused medical devices.
Aurora Spine (OTCQB: ASAPF), a developer of innovative spinal surgery devices, will participate in the Sixth Annual American Society of Pain & Neuroscience (ASPN) Conference from July 11-14, 2024, in Miami Beach, Florida. Aurora will showcase its products at Booth 121 and host a product theater on July 12th at 10:15 a.m.
During the event, prominent physicians Dr. Pankaj Mehta, Dr. Steven Falowski, and Dr. Jason Pope will present findings from Aurora Spine’s Refine Study. This study is the first multi-center, multi-specialty, randomized control trial focusing on interlaminar fusion, comparing Aurora’s SILO TFX and ZIP 51 devices. Aurora's President and CEO, Trent Northcutt, expressed enthusiasm for the opportunity to present their cutting-edge products and clinical results to leading physicians.
Aurora Spine has scheduled a conference call to update investors and discuss its first quarter fiscal 2024 financial results. The call will take place on May 14, 2024, at 11:00 a.m. Eastern Time. Interested parties can access the call via dial-in or webcast. A replay will be available for a time.
FAQ
What is the current stock price of Aurora Spine (ASAPF)?
What is the market cap of Aurora Spine (ASAPF)?
